Team Careers Products Medical Affairs News Contact

Team Careers Products Medical Affairs News Contact

Back

In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline

June 29, 2018

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

Team Careers Products Medical Affairs - Report Adverse Events - Report Product Complaints News Contact

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

© 2024 INNOVIVA SPECIALTY THERAPEUTICS | ALL RIGHTS RESERVED